A congestive heart failure project with measured improvements in care

Evaluation and the Health Professions

Volumn 21, Issue 4, 1998, Pages 472-486

  DeLong, James F ^a   Allman, Richard M ^a   Sherrill, Robert G ^a   Schiesz, Nadine ^a  

^a Alabama Quality Assurance Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONGESTIVE HEART FAILURE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MEDICARE; PATIENT CARE; PHYSICIAN ATTITUDE; REVIEW; STATISTICAL ANALYSIS;

EID: 0031785902     PISSN: 01632787     EISSN: None     Source Type: Journal    
DOI: 10.1177/016327879802100406     Document Type: Review

References (18)

1. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. (1993). Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet, 342, 821-828.
2. Aguirre, F. V., Pearson, A. C., Lewen, M. D., McCluskey, M., & Labovitz, A. J. (1989). Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure. American Journal of Cardiology, 63, 1098-1102.
3. Aronow, W. S., Ahn, C., & Kronzon, I. (1990). Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. American Journal of Cardiology, 66, 1257-1259.
4. Bonow, R. O., & Udelson, J. E. (1992). Left ventricular diastolic dysfunction as a cause of congestive heart failure: Mechanism and management. Annals of Internal Medicine, 117, 502-510.
5. Chakko, C. S., Woska, D., Martinez, H., De Marchena, E., Futterman, L., Kessler. K., & Myerberg, R., (1991). Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: Conflicting results may lead to inappropriate care. American Journal of Medicine, 90, 353-359.
6. Cody, R. J. (1994). Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction. Archives of Internal Medicine, 154, 2029-2036.
7. CONSENSUS Trial Study Group. (1987). Effects of enalapril on mortality in severe congestive heart failure. New England Journal of Medicine, 316, 1429-1435.
8. Dougherty, A. H., Naccarelli, G. V., Gray, E. L., Hicks, C., & Goldstein, R. (1984). Congestive heart failure with normal systolic function. Amercian Journal of Cardiology, 54, 778-782.
9. Ellerbeck, E. F., Jencks, S. F., Radford, M. J., Dresowik, T. F., Craig, A. S., Gold, J. A., Krumholz, H. M., & Vogel, R. A. (1995). Quality of care of Medicare patients with acute myocardial infarction: A four-state pilot study from the Cooperative Cardiovascular Project. Journal of the American Medical Association, 273, 1509-1514.
10. Ghali, J. K., Giles, T., Gonzales, M., Horswell, R., Kumar, S., Lejeune, A., Livaudais, G., & Sarkar, I. (1997). Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure. Louisiana State Society of Medicine Journal, 749(12), 474-484.
11. Goldsmith, S. R., & Dick, C. (1993). Differentiating systolic from diastolic heart failure: Pathophysiologic and therapeutic considerations. American Journal of Medicine, 95, 645-655.
12. Kannel, W. B., & Belanger, A. J. (1991). Epidemiology of heart American Heart Journal, 121, 951-957.
13. Konstam, M., Dracup, K., Bottorff, M., Brooks, N.H., Dacey, R., Dunbar, S., Jackson, A., Jessup, M., Johnson, J. C., Jones, R. H., Luchi, R., Massie, B., Pitt, B., Rose, E., Rubin, L., & Wright, R. F. (1994). Heart failure: Evaluation and care of patients with left-ventricular systolic dysfunction. Clinical Practice Guideline No. 11. AHCPR Publication No. 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services.
14. Marciniak, T. A., Ellerbeck, E. F., Radford, M. J., Kresowik, T. F., Gold, J. A., Krumholz, H. M., Kiefe, C. I., Allman, R. M., Vogel, R. A., & Jencks, S. F. (1998). Improving the quality of care for Medicare patients with acute myocardial infarction. Journal of the American Medical Association, 279, 1351-1357.
15. Pfeffer, M. A., Braunwald, E., Moye, L. A., Basta, L., Brown, E., Cuddy, T., Davis, B., Geltman, E., Goldman, S., Flaker, G., Klein, M., Lamas, G., Packer, M., Rouleau, J., Rouleau, J. L., Rutherford, J., Wertheimer, J., & Hawkins, C. M., on behalf of the SAVE Investigators. (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results for the Survival and Ventricular Enlargement Trial. New England Journal of Medicine, 327, 669-677.
16. SOLVD Investigators. (1991). Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine, 325, 293-302.
17. SOLVD Investigators. (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine, 327, 685-691.
18. Swedburg, K., Helf, P., Kjekshus, J., Rasmussen, K., Ryden, L., & Wedel, H. (1992). Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results for the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). New England Journal of Medicine, 327, 678-684.